P.030 Long-term Safety and Tolerability of Atogepant 60 mg Following Once-Daily Dosing Over 1 Year for the Preventive Treatment of Migraine

Background: The goal of the study was to assess the safety and tolerability of atogepant, an oral, calcitonin gene-related peptide receptor antagonist in development for migraine preventive treatment, once daily over 1 year. Methods: Multicenter, open-label trial (NCT03700320). Adults with migraine...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Canadian journal of neurological sciences 2021-11, Vol.48 (s3), p.S28-S29
Hauptverfasser:	Ashina, M, Tepper, SJ, Reuter, U, Blumenfeld, AM, Hutchinson, S, Xia, J, Davidovic, G, Miceli, R, Severt, L, Finnegan, M, Trugman, JM
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Neurology (CNS) Headache Migraine Murders & murder attempts Poster Presentations
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!